3-N-Butylphthalide
The risk or severity of adverse effects can be increased when Butylphthalide is combined with Acetylsalicylic acid.
Abciximab
The risk or severity of adverse effects can be increased when Abciximab is combined with Acetylsalicylic acid.
Abiraterone
The serum concentration of Acetylsalicylic acid can be increased when it is combined with Abiraterone.
Advertisement
Acarbose
Acetylsalicylic acid may increase the hypoglycemic activities of Acarbose.
Acebutolol
Acetylsalicylic acid may decrease the antihypertensive activities of Acebutolol.
Acemetacin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Acemetacin.
Advertisement
Acenocoumarol
Acetylsalicylic acid may increase the anticoagulant activities of Acenocoumarol.
Acetazolamide
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Acetazolamide.
Acetyl Sulfisoxazole
The metabolism of Acetylsalicylic acid can be decreased when combined with Acetyl sulfisoxazole.
Advertisement
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Acetylsalicylic acid.
Albiglutide
Acetylsalicylic acid may increase the hypoglycemic activities of Albiglutide.
Alclometasone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Alclometasone.
Aldosterone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Aldosterone.
Alendronate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Alendronic acid.
Alendronic acid
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Alendronic acid.
Aliskiren
Acetylsalicylic acid may decrease the antihypertensive activities of Aliskiren.
Alminoprofen
The risk or severity of adverse effects can be increased when Alminoprofen is combined with Acetylsalicylic acid.
Alogliptin
Acetylsalicylic acid may increase the hypoglycemic activities of Alogliptin.
Aloxiprin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Aloxiprin.
alpha Tocopherol
Vitamin E may increase the antiplatelet activities of Acetylsalicylic acid.
Alprenolol
Acetylsalicylic acid may decrease the antihypertensive activities of Alprenolol.
Alprostadil
The risk or severity of adverse effects can be increased when Alprostadil is combined with Acetylsalicylic acid.
Alteplase
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Alteplase.
Amcinonide
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Amcinonide.
Amikacin
Acetylsalicylic acid may decrease the excretion rate of Amikacin which could result in a higher serum level.
Amiloride
Acetylsalicylic acid may decrease the antihypertensive activities of Amiloride.
Amiodarone
The metabolism of Acetylsalicylic acid can be decreased when combined with Amiodarone.
Ammonium Chloride
The serum concentration of Acetylsalicylic acid can be increased when it is combined with Ammonium chloride.
Anagrelide
The risk or severity of adverse effects can be increased when Anagrelide is combined with Acetylsalicylic acid.
Ancrod
Acetylsalicylic acid may increase the anticoagulant activities of Ancrod.
Androstenedione
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Androstenedione.
Anhydrous Tacrolimus
Acetylsalicylic acid may increase the nephrotoxic activities of Tacrolimus.
Anistreplase
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Anistreplase.
Antithrombin III
Acetylsalicylic acid may increase the anticoagulant activities of Antithrombin III human.
Antithrombin III, Human
Acetylsalicylic acid may increase the anticoagulant activities of Antithrombin III human.
Apalutamide
The serum concentration of Acetylsalicylic acid can be decreased when it is combined with Apalutamide.
Apazone
The risk or severity of adverse effects can be increased when Azapropazone is combined with Acetylsalicylic acid.
Apixaban
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Apixaban.
Apremilast
The risk or severity of adverse effects can be increased when Apremilast is combined with Acetylsalicylic acid.
Aprepitant
The metabolism of Acetylsalicylic acid can be increased when combined with Aprepitant.
Aprotinin
The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Aprotinin.
Arbekacin
Acetylsalicylic acid may decrease the excretion rate of Arbekacin which could result in a higher serum level.
Ardeparin
Acetylsalicylic acid may increase the anticoagulant activities of Ardeparin.
Argatroban
The risk or severity of adverse effects can be increased when Argatroban is combined with Acetylsalicylic acid.
Argatroban Anhydrous
The risk or severity of adverse effects can be increased when Argatroban is combined with Acetylsalicylic acid.
Asenapine
Acetylsalicylic acid may decrease the antihypertensive activities of Asenapine.
Astaxanthin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Astaxanthin.
Atenolol
Acetylsalicylic acid may decrease the antihypertensive activities of Atenolol.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Acetylsalicylic acid.
azficel-T
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Azficel-T.
Azilsartan
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Acetylsalicylic acid.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Acetylsalicylic acid.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Acetylsalicylic acid.
Azosemide
The therapeutic efficacy of Azosemide can be decreased when used in combination with Acetylsalicylic acid.
Bazedoxifene
Acetylsalicylic acid may increase the thrombogenic activities of Bazedoxifene.
Becaplermin
Acetylsalicylic acid may increase the anticoagulant activities of Becaplermin.
Beclomethasone Dipropionate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Beclomethasone dipropionate.
Bemiparin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Bemiparin.
Benazepril
The therapeutic efficacy of Benazepril can be decreased when used in combination with Acetylsalicylic acid.
Bendroflumethiazide
The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Acetylsalicylic acid.
Benzthiazide
The therapeutic efficacy of Benzthiazide can be decreased when used in combination with Acetylsalicylic acid.
Benzydamine
The risk or severity of adverse effects can be increased when Benzydamine is combined with Acetylsalicylic acid.
Betamethasone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Betamethasone.
Betaxolol
Acetylsalicylic acid may decrease the antihypertensive activities of Betaxolol.
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Acetylsalicylic acid.
Bimatoprost
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Acetylsalicylic acid.
Bisoprolol
Acetylsalicylic acid may decrease the antihypertensive activities of Bisoprolol.
Bivalirudin
Acetylsalicylic acid may increase the anticoagulant activities of Bivalirudin.
Bopindolol
Acetylsalicylic acid may decrease the antihypertensive activities of Bopindolol.
Brinzolamide
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Brinzolamide.
Bromocriptine
Acetylsalicylic acid may increase the hypoglycemic activities of Bromocriptine.
Budesonide
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Budesonide.
Bumetanide
The therapeutic efficacy of Bumetanide can be decreased when used in combination with Acetylsalicylic acid.
Bupranolol
Acetylsalicylic acid may decrease the antihypertensive activities of Bupranolol.
Canagliflozin
Acetylsalicylic acid may increase the hypoglycemic activities of Canagliflozin.
Canagliflozin Anhydrous
Acetylsalicylic acid may increase the hypoglycemic activities of Canagliflozin.
Candesartan
The risk or severity of adverse effects can be increased when Candesartan is combined with Acetylsalicylic acid.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Acetylsalicylic acid.
Cangrelor
The risk or severity of adverse effects can be increased when Cangrelor is combined with Acetylsalicylic acid.
Capecitabine
The metabolism of Acetylsalicylic acid can be decreased when combined with Capecitabine.
Captopril
The therapeutic efficacy of Captopril can be decreased when used in combination with Acetylsalicylic acid.
Carbamazepine
The metabolism of Acetylsalicylic acid can be increased when combined with Carbamazepine.
Carboprost
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Acetylsalicylic acid.
Carboprost Tromethamine
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Acetylsalicylic acid.
Carisoprodol
The serum concentration of the active metabolites of Carisoprodol can be increased when Carisoprodol is used in combination with Acetylsalicylic acid.
Carteolol
Acetylsalicylic acid may decrease the antihypertensive activities of Carteolol.
Carvedilol
Acetylsalicylic acid may decrease the antihypertensive activities of Carvedilol.
Celecoxib
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Celecoxib.
Celiprolol
Acetylsalicylic acid may decrease the antihypertensive activities of Celiprolol.
Ceritinib
The serum concentration of Acetylsalicylic acid can be increased when it is combined with Ceritinib.
Certoparin
Acetylsalicylic acid may increase the anticoagulant activities of Certoparin.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Acetylsalicylic acid.
Chlorothiazide
The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Acetylsalicylic acid.
Chlorotrianisene
Acetylsalicylic acid may increase the thrombogenic activities of Chlorotrianisene.
Chlorpropamide
Acetylsalicylic acid may increase the hypoglycemic activities of Chlorpropamide.
Chlorthalidone
The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Acetylsalicylic acid.
Cholecalciferol
The metabolism of Acetylsalicylic acid can be decreased when combined with Cholecalciferol.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Acetylsalicylic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ciclesonide
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ciclesonide.
Cilazapril
The therapeutic efficacy of Cilazapril can be decreased when used in combination with Acetylsalicylic acid.
Cilostazol
The risk or severity of adverse effects can be increased when Cilostazol is combined with Acetylsalicylic acid.
Cinoxacin
Acetylsalicylic acid may increase the neuroexcitatory activities of Cinoxacin.
Ciprofloxacin
Acetylsalicylic acid may increase the neuroexcitatory activities of Ciprofloxacin.
Citalopram
Citalopram may increase the antiplatelet activities of Acetylsalicylic acid.
Citric Acid
Acetylsalicylic acid may increase the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Acetylsalicylic acid may increase the anticoagulant activities of Citric Acid.
Clobetasol
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Clobetasol.
Clobetasol Propionate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Clobetasol propionate.
Clobetasone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Clobetasone.
Clocortolone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Clocortolone.
Clofezone
The metabolism of Acetylsalicylic acid can be decreased when combined with Rabeprazole.
Clonixin
The risk or severity of adverse effects can be increased when Clonixin is combined with Acetylsalicylic acid.
Clopidogrel
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Acetylsalicylic acid.
Clotrimazole
The metabolism of Acetylsalicylic acid can be decreased when combined with Clotrimazole.
Colesevelam
Colesevelam can cause a decrease in the absorption of Acetylsalicylic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Acetylsalicylic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
COLLAGENASE
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Collagenase clostridium histolyticum.
collagenase Clostridium histolyticum
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Collagenase clostridium histolyticum.
Cortisone Acetate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Cortisone acetate.
Crisaborole
The metabolism of Acetylsalicylic acid can be decreased when combined with Crisaborole.
Curcumin
The risk or severity of adverse effects can be increased when Curcumin is combined with Acetylsalicylic acid.
Cyclopenthiazide
The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Acetylsalicylic acid.
Cyclosporine
Acetylsalicylic acid may increase the nephrotoxic activities of Cyclosporine.
Dabigatran Etexilate
Acetylsalicylic acid may increase the anticoagulant activities of Dabigatran etexilate.
Dabrafenib
The serum concentration of Acetylsalicylic acid can be decreased when it is combined with Dabrafenib.
Dalteparin
Acetylsalicylic acid may increase the anticoagulant activities of Dalteparin.
Danaparoid
Acetylsalicylic acid may increase the anticoagulant activities of Danaparoid.
Dapagliflozin
Acetylsalicylic acid may increase the hypoglycemic activities of Dapagliflozin.
Dasatinib
Dasatinib may increase the anticoagulant activities of Acetylsalicylic acid.
Dasatinib Anhydrous
Dasatinib may increase the anticoagulant activities of Acetylsalicylic acid.
Deferasirox
The serum concentration of Acetylsalicylic acid can be increased when it is combined with Deferasirox.
Defibrotide
The risk or severity of adverse effects can be increased when Defibrotide is combined with Acetylsalicylic acid.
Deflazacort
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Deflazacort.
Delavirdine
The metabolism of Acetylsalicylic acid can be decreased when combined with Delavirdine.
Deoxycholate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Deoxycholic Acid.
Deoxycholic Acid
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Deoxycholic Acid.
Desipramine
Acetylsalicylic acid may decrease the antihypertensive activities of Desipramine.
Desirudin
Acetylsalicylic acid may increase the anticoagulant activities of Desirudin.
Desmopressin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Desmopressin.
Desonide
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Desonide.
Desoximetasone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Desoximetasone.
Desoxycorticosterone acetate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Desoxycorticosterone acetate.
Desoxycorticosterone Pivalate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Desoxycorticosterone Pivalate.
Desvenlafaxine
Desvenlafaxine may increase the antiplatelet activities of Acetylsalicylic acid.
Dexamethasone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Dexamethasone.
Dexketoprofen
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Dexketoprofen.
Dextran
Acetylsalicylic acid may increase the anticoagulant activities of Dextran.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Diclofenamide.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Acetylsalicylic acid.
Dicumarol
Acetylsalicylic acid may increase the anticoagulant activities of Dicoumarol.
Dienestrol
Acetylsalicylic acid may increase the thrombogenic activities of Dienestrol.
Diethylstilbestrol
Acetylsalicylic acid may increase the thrombogenic activities of Diethylstilbestrol.
Diflorasone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Diflorasone.
Diflucortolone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Difluocortolone.
Difluprednate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Difluprednate.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Acetylsalicylic acid.
Dihydrostreptomycin
Acetylsalicylic acid may decrease the excretion rate of Dihydrostreptomycin which could result in a higher serum level.
Diltiazem
Diltiazem may increase the anticoagulant activities of Acetylsalicylic acid.
Dinoprost
The therapeutic efficacy of Dinoprost can be decreased when used in combination with Acetylsalicylic acid.
Dinoprost Tromethamine
The therapeutic efficacy of Dinoprost Tromethamine can be decreased when used in combination with Acetylsalicylic acid.
Dinoprostone
The therapeutic efficacy of Dinoprostone can be decreased when used in combination with Acetylsalicylic acid.
Dipyridamole
The risk or severity of adverse effects can be increased when Dipyridamole is combined with Acetylsalicylic acid.
Dipyrone
The risk or severity of adverse effects can be increased when Metamizole is combined with Acetylsalicylic acid.
Disopyramide
Acetylsalicylic acid may increase the hypoglycemic activities of Disopyramide.
Dorzolamide
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Dorzolamide.
Dothiepin
The metabolism of Acetylsalicylic acid can be decreased when combined with Dosulepin.
Drospirenone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Drospirenone.
Drotrecogin Alfa
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Drotrecogin alfa.
Dulaglutide
Acetylsalicylic acid may increase the hypoglycemic activities of Dulaglutide.
Duloxetine
Duloxetine may increase the antiplatelet activities of Acetylsalicylic acid.
Edetic Acid
Acetylsalicylic acid may increase the anticoagulant activities of Edetic Acid.
Edoxaban
Acetylsalicylic acid may increase the anticoagulant activities of Edoxaban.
Efavirenz
The metabolism of Acetylsalicylic acid can be decreased when combined with Efavirenz.
Empagliflozin
Acetylsalicylic acid may increase the hypoglycemic activities of Empagliflozin.
Enalapril
The therapeutic efficacy of Enalapril can be decreased when used in combination with Acetylsalicylic acid.
Enalaprilat
The therapeutic efficacy of Enalaprilat can be decreased when used in combination with Acetylsalicylic acid.
Enalaprilat Anhydrous
The therapeutic efficacy of Enalaprilat can be decreased when used in combination with Acetylsalicylic acid.
Enoxacin
Acetylsalicylic acid may increase the neuroexcitatory activities of Enoxacin.
Enoxaparin
Acetylsalicylic acid may increase the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Acetylsalicylic acid may increase the anticoagulant activities of Enoxaparin.
Epinastine
The risk or severity of adverse effects can be increased when Epinastine is combined with Acetylsalicylic acid.
Eplerenone
Acetylsalicylic acid may decrease the antihypertensive activities of Eplerenone.
Epoprostenol
The risk or severity of adverse effects can be increased when Epoprostenol is combined with Acetylsalicylic acid.
Eprosartan
The risk or severity of adverse effects can be increased when Eprosartan is combined with Acetylsalicylic acid.
Eptifibatide
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Acetylsalicylic acid.
Equol, (-)-
Acetylsalicylic acid may increase the thrombogenic activities of Equol.
Escitalopram
Escitalopram may increase the antiplatelet activities of Acetylsalicylic acid.
Esmolol
Acetylsalicylic acid may decrease the antihypertensive activities of Esmolol.
Estradiol
Acetylsalicylic acid may increase the thrombogenic activities of Estradiol.
Estradiol acetate
Acetylsalicylic acid may increase the thrombogenic activities of Estradiol acetate.
Estradiol Cypionate
Acetylsalicylic acid may increase the thrombogenic activities of Estradiol cypionate.
Estradiol Valerate
Acetylsalicylic acid may increase the thrombogenic activities of Estradiol valerate.
Estriol
Acetylsalicylic acid may increase the thrombogenic activities of Estriol.
Estrogens, Conjugated (USP)
Acetylsalicylic acid may increase the thrombogenic activities of Conjugated estrogens.
Estrogens, Esterified (USP)
Acetylsalicylic acid may increase the thrombogenic activities of Estrogens, esterified.
Estrone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Estrone.
Ethacrynate
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Acetylsalicylic acid.
Ethacrynic Acid
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Acetylsalicylic acid.
Ethanol
The risk or severity of adverse effects can be increased when Ethanol is combined with Acetylsalicylic acid.
Ethinyl Estradiol
Acetylsalicylic acid may increase the thrombogenic activities of Ethinyl Estradiol.
Ethylenediaminetetraacetate
Acetylsalicylic acid may increase the anticoagulant activities of Edetic Acid.
Etidronate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Etidronic acid.
Etidronic Acid
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Etidronic acid.
Etodolac
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Etodolac.
Etofenamate
The risk or severity of adverse effects can be increased when Etofenamate is combined with Acetylsalicylic acid.
Etoricoxib
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Etoricoxib.
Etravirine
The metabolism of Acetylsalicylic acid can be decreased when combined with Etravirine.
Evening primrose oil
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Acetylsalicylic acid.
Exenatide
Acetylsalicylic acid may increase the hypoglycemic activities of Exenatide.
Felbinac
The risk or severity of adverse effects can be increased when Felbinac is combined with Acetylsalicylic acid.
Felodipine
The metabolism of Acetylsalicylic acid can be decreased when combined with Felodipine.
Fenbufen
The risk or severity of adverse effects can be increased when Fenbufen is combined with Acetylsalicylic acid.
Ferulic Acid
The risk or severity of adverse effects can be increased when Ferulic acid is combined with Acetylsalicylic acid.
Fibrinolysis Inhibitor
The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Aprotinin.
Fleroxacin
Acetylsalicylic acid may increase the neuroexcitatory activities of Fleroxacin.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Acetylsalicylic acid.
Floxuridine
The metabolism of Acetylsalicylic acid can be decreased when combined with Floxuridine.
Fluconazole
The metabolism of Acetylsalicylic acid can be decreased when combined with Fluconazole.
Fludrocortisone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fludrocortisone.
Fluindione
Acetylsalicylic acid may increase the anticoagulant activities of Fluindione.
Flumequine
Acetylsalicylic acid may increase the neuroexcitatory activities of Flumequine.
Flumethasone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Flumethasone.
Flunisolide
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Flunisolide.
Flunisolide Anhydrous (obsolete)
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Flunisolide.
Fluocinolone Acetonide
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fluocinolone Acetonide.
Fluocinonide
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fluocinonide.
Fluocortolone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fluocortolone.
Fluorometholone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fluorometholone.
Fluorouracil
The metabolism of Acetylsalicylic acid can be decreased when combined with Fluorouracil.
Fluoxetine
Fluoxetine may increase the antiplatelet activities of Acetylsalicylic acid.
FLUPREDNIDENE
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fluprednidene.
Fluprednisolone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fluprednisolone.
Flurandrenolide
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Flurandrenolide.
Fluticasone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fluticasone.
Fluticasone Furoate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fluticasone furoate.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fluticasone propionate.
Fluvastatin
The metabolism of Acetylsalicylic acid can be decreased when combined with Fluvastatin.
Fluvoxamine
Fluvoxamine may increase the antiplatelet activities of Acetylsalicylic acid.
Folate
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Acetylsalicylic acid.
Folic Acid
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Acetylsalicylic acid.
Fondaparinux sodium
Acetylsalicylic acid may increase the anticoagulant activities of Fondaparinux sodium.
Formestane
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Formestane.
Fosinopril
The therapeutic efficacy of Fosinopril can be decreased when used in combination with Acetylsalicylic acid.
Fosphenytoin
The metabolism of Acetylsalicylic acid can be increased when combined with Fosphenytoin.
Framycetin
Acetylsalicylic acid may decrease the excretion rate of Framycetin which could result in a higher serum level.
Furosemide
The therapeutic efficacy of Furosemide can be decreased when used in combination with Acetylsalicylic acid.
Gatifloxacin
Acetylsalicylic acid may increase the neuroexcitatory activities of Gatifloxacin.
Gatifloxacin Anhydrous
Acetylsalicylic acid may increase the neuroexcitatory activities of Gatifloxacin.
Gemeprost
The therapeutic efficacy of Gemeprost can be decreased when used in combination with Acetylsalicylic acid.
Gemfibrozil
The metabolism of Acetylsalicylic acid can be decreased when combined with Gemfibrozil.
Gemifloxacin
Acetylsalicylic acid may increase the neuroexcitatory activities of Gemifloxacin.
Gemifloxacin Mesylate
Acetylsalicylic acid may increase the neuroexcitatory activities of Gemifloxacin.
Genistein
Acetylsalicylic acid may increase the thrombogenic activities of Genistein.
Gentamicin
Acetylsalicylic acid may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Ginkgo biloba extract
Ginkgo biloba may increase the anticoagulant activities of Acetylsalicylic acid.
Gliclazide
Acetylsalicylic acid may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Acetylsalicylic acid may increase the hypoglycemic activities of Glimepiride.
Glipizide
Acetylsalicylic acid may increase the hypoglycemic activities of Glipizide.
Glucosamine
Glucosamine may increase the antiplatelet activities of Acetylsalicylic acid.
Glyburide
Acetylsalicylic acid may increase the hypoglycemic activities of Glyburide.
Grepafloxacin
Acetylsalicylic acid may increase the neuroexcitatory activities of Grepafloxacin.
Halcinonide
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Halcinonide.
Halobetasol
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ulobetasol.
Haloperidol
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Haloperidol.
Heparin
Acetylsalicylic acid may increase the anticoagulant activities of Heparin.
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Acetylsalicylic acid.
Hyaluronidase, Ovine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Acetylsalicylic acid.
Hydralazine
Acetylsalicylic acid may decrease the antihypertensive activities of Hydralazine.
Hydrochlorothiazide
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Acetylsalicylic acid.
Hydrocortisone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Acetylsalicylic acid.
Hydroxytyrosol
The risk or severity of adverse effects can be increased when Hydroxytyrosol is combined with Acetylsalicylic acid.
Ibandronate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ibandronate.
Ibandronic Acid
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ibandronate.
Ibritumomab Tiuxetan
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ibritumomab tiuxetan.
Ibrutinib
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Acetylsalicylic acid.
Icatibant
The risk or severity of adverse effects can be increased when Icatibant is combined with Acetylsalicylic acid.
Icosapent Ethyl
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Acetylsalicylic acid.
Ifenprodil
The risk or severity of adverse effects can be increased when Ifenprodil is combined with Acetylsalicylic acid.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Acetylsalicylic acid.
Imidapril
The therapeutic efficacy of Imidapril can be decreased when used in combination with Acetylsalicylic acid.
Indapamide
The therapeutic efficacy of Indapamide can be decreased when used in combination with Acetylsalicylic acid.
Indinavir
The metabolism of Acetylsalicylic acid can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Acetylsalicylic acid can be decreased when combined with Indinavir.
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Acetylsalicylic acid.
Insulin Detemir
Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Detemir.
Insulin Glargine
Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Glargine.
insulin human, rDNA origin
Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Human.
Insulin Lispro
Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Lispro.
Insulin, Aspart Protamine, Human
Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Aspart, Human
Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Glulisine, Human
Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Glulisine.
Insulin, Protamine Lispro, Human
Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Lispro.
Irbesartan
The metabolism of Acetylsalicylic acid can be decreased when combined with Irbesartan.
Isavuconazole
The serum concentration of Acetylsalicylic acid can be increased when it is combined with Isavuconazole.
Kanamycin
Acetylsalicylic acid may decrease the excretion rate of Kanamycin which could result in a higher serum level.
kanamycin A
Acetylsalicylic acid may decrease the excretion rate of Kanamycin which could result in a higher serum level.
Kebuzone
The risk or severity of adverse effects can be increased when Kebuzone is combined with Acetylsalicylic acid.
Ketanserin
The risk or severity of adverse effects can be increased when Ketanserin is combined with Acetylsalicylic acid.
Ketoconazole
The metabolism of Acetylsalicylic acid can be decreased when combined with Ketoconazole.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Acetylsalicylic acid.
Labetalol
Acetylsalicylic acid may decrease the antihypertensive activities of Labetalol.
Lapatinib
The metabolism of Acetylsalicylic acid can be decreased when combined with Lapatinib.
Latanoprost
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Acetylsalicylic acid.
Latanoprostene Bunod
The therapeutic efficacy of Latanoprostene Bunod can be decreased when used in combination with Acetylsalicylic acid.
Leflunomide
The risk or severity of adverse effects can be increased when Leflunomide is combined with Acetylsalicylic acid.
Lepirudin
Acetylsalicylic acid may increase the anticoagulant activities of Lepirudin.
Levobetaxolol
Acetylsalicylic acid may decrease the antihypertensive activities of Levobetaxolol.
Levobunolol
Acetylsalicylic acid may decrease the antihypertensive activities of Levobunolol.
Levofloxacin
Acetylsalicylic acid may increase the neuroexcitatory activities of Levofloxacin.
Levofloxacin Anhydrous
Acetylsalicylic acid may increase the neuroexcitatory activities of Levofloxacin.
Levomilnacipran
Levomilnacipran may increase the antiplatelet activities of Acetylsalicylic acid.
Limonene, (+)-
The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Acetylsalicylic acid.
Liraglutide
Acetylsalicylic acid may increase the hypoglycemic activities of Liraglutide.
Lisinopril
The therapeutic efficacy of Lisinopril can be decreased when used in combination with Acetylsalicylic acid.
Lisinopril Anhydrous
The therapeutic efficacy of Lisinopril can be decreased when used in combination with Acetylsalicylic acid.
Lithium
The serum concentration of Lithium can be increased when it is combined with Acetylsalicylic acid.
Lithium Cation
The serum concentration of Lithium can be increased when it is combined with Acetylsalicylic acid.
Lomefloxacin
Acetylsalicylic acid may increase the neuroexcitatory activities of Lomefloxacin.
Losartan
The metabolism of Acetylsalicylic acid can be decreased when combined with Losartan.
Loteprednol
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Loteprednol.
Lovastatin
The metabolism of Acetylsalicylic acid can be decreased when combined with Lovastatin.
Loxoprofen
The risk or severity of adverse effects can be increased when Loxoprofen is combined with Acetylsalicylic acid.
Lubiprostone
The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Acetylsalicylic acid.
Lumacaftor
The serum concentration of Acetylsalicylic acid can be increased when it is combined with Lumacaftor.
Manidipine
The metabolism of Acetylsalicylic acid can be decreased when combined with Manidipine.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Acetylsalicylic acid.
Mecasermin
Acetylsalicylic acid may increase the hypoglycemic activities of Mecasermin.
Mecasermin Rinfabate
Acetylsalicylic acid may increase the hypoglycemic activities of Mecasermin.
Medronate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Technetium Tc-99m medronate.
Medrysone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Medrysone.
Mepindolol
Acetylsalicylic acid may decrease the antihypertensive activities of Mepindolol.
Mestranol
Acetylsalicylic acid may increase the thrombogenic activities of Mestranol.
Metformin
Acetylsalicylic acid may increase the hypoglycemic activities of Metformin.
Methazolamide
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Methazolamide.
Methotrexate
The serum concentration of Methotrexate can be increased when it is combined with Acetylsalicylic acid.
Methyclothiazide
The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Acetylsalicylic acid.
Methyl Salicylate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Methyl salicylate.
Methylprednisolone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Methylprednisolone.
Metipranolol
Acetylsalicylic acid may decrease the antihypertensive activities of Metipranolol.
Metolazone
The therapeutic efficacy of Metolazone can be decreased when used in combination with Acetylsalicylic acid.
Metoprolol
Acetylsalicylic acid may decrease the antihypertensive activities of Metoprolol.
Midostaurin
The metabolism of Acetylsalicylic acid can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Acetylsalicylic acid can be increased when it is combined with Mifepristone.
Miglitol
Acetylsalicylic acid may increase the hypoglycemic activities of Miglitol.
Milnacipran
Milnacipran may increase the antiplatelet activities of Acetylsalicylic acid.
Milrinone
The risk or severity of adverse effects can be increased when Milrinone is combined with Acetylsalicylic acid.
Misoprostol
The therapeutic efficacy of Misoprostol can be decreased when used in combination with Acetylsalicylic acid.
Moexipril
The therapeutic efficacy of Moexipril can be decreased when used in combination with Acetylsalicylic acid.
Mometasone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Mometasone.
Morniflumate
The risk or severity of adverse effects can be increased when Morniflumate is combined with Acetylsalicylic acid.
Moxifloxacin
Acetylsalicylic acid may increase the neuroexcitatory activities of Moxifloxacin.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Acetylsalicylic acid.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Acetylsalicylic acid.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Acetylsalicylic acid.
Nabilone
The metabolism of Acetylsalicylic acid can be decreased when combined with Nabilone.
Nabumetone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Nabumetone.
Nadolol
Acetylsalicylic acid may decrease the antihypertensive activities of Nadolol.
Nadroparin
Acetylsalicylic acid may increase the anticoagulant activities of Nadroparin.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Acetylsalicylic acid.
Nalidixic Acid
Acetylsalicylic acid may increase the neuroexcitatory activities of Nalidixic Acid.
Nateglinide
Acetylsalicylic acid may increase the hypoglycemic activities of Nateglinide.
Nebivolol
Acetylsalicylic acid may decrease the antihypertensive activities of Nebivolol.
Nefazodone
Nefazodone may increase the antiplatelet activities of Acetylsalicylic acid.
Neomycin
Acetylsalicylic acid may decrease the excretion rate of Neomycin which could result in a higher serum level.
Netilmicin
Acetylsalicylic acid may decrease the excretion rate of Netilmicin which could result in a higher serum level.
Nicardipine
The metabolism of Acetylsalicylic acid can be decreased when combined with Nicardipine.
Nicorandil
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Nicorandil.
Nilotinib
The metabolism of Acetylsalicylic acid can be decreased when combined with Nilotinib.
Norfloxacin
Acetylsalicylic acid may increase the neuroexcitatory activities of Norfloxacin.
Obinutuzumab
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Obinutuzumab.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Acetylsalicylic acid.
Ofloxacin
Acetylsalicylic acid may increase the neuroexcitatory activities of Ofloxacin.
Olmesartan
The risk or severity of adverse effects can be increased when Olmesartan is combined with Acetylsalicylic acid.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Acetylsalicylic acid.
Olsalazine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Acetylsalicylic acid.
Omacetaxine Mepesuccinate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Omacetaxine mepesuccinate.
Omega-3 Fatty Acids
Omega-3 fatty acids may increase the antiplatelet activities of Acetylsalicylic acid.
Omeprazole
The metabolism of Acetylsalicylic acid can be decreased when combined with Omeprazole.
Oxprenolol
Acetylsalicylic acid may decrease the antihypertensive activities of Oxprenolol.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Acetylsalicylic acid.
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Acetylsalicylic acid.
Pamidronate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Pamidronate.
Pamidronic Acid
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Pamidronate.
Paramethasone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Paramethasone.
Parecoxib
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Parecoxib.
Parnaparin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Parnaparin.
Paromomycin
Acetylsalicylic acid may decrease the excretion rate of Paromomycin which could result in a higher serum level.
Paroxetine
Paroxetine may increase the antiplatelet activities of Acetylsalicylic acid.
Parthenolide
The risk or severity of adverse effects can be increased when Parthenolide is combined with Acetylsalicylic acid.
Pefloxacin
Acetylsalicylic acid may increase the neuroexcitatory activities of Pefloxacin.
Penbutolol
Acetylsalicylic acid may decrease the antihypertensive activities of Penbutolol.
Pentaerythritol Tetranitrate
Acetylsalicylic acid may increase the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentamidine
Acetylsalicylic acid may increase the hypoglycemic activities of Pentamidine.
Pentosan Polysulfate
The risk or severity of adverse effects can be increased when Pentosan Polysulfate is combined with Acetylsalicylic acid.
Pentoxifylline
Pentoxifylline may increase the antiplatelet activities of Acetylsalicylic acid.
Perindopril
The therapeutic efficacy of Perindopril can be decreased when used in combination with Acetylsalicylic acid.
Phenindione
Acetylsalicylic acid may increase the anticoagulant activities of Phenindione.
Phenobarbital
The metabolism of Acetylsalicylic acid can be increased when combined with Phenobarbital.
Phenprocoumon
Acetylsalicylic acid may increase the anticoagulant activities of Phenprocoumon.
Phenytoin
The metabolism of Acetylsalicylic acid can be increased when combined with Phenytoin.
Phospholipids
Omega-3 fatty acids may increase the antiplatelet activities of Acetylsalicylic acid.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Acetylsalicylic acid.
Pindolol
Acetylsalicylic acid may decrease the antihypertensive activities of Pindolol.
Pioglitazone
The metabolism of Acetylsalicylic acid can be decreased when combined with Pioglitazone.
Piretanide
The therapeutic efficacy of Piretanide can be decreased when used in combination with Acetylsalicylic acid.
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Acetylsalicylic acid.
Plasmin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fibrinolysin.
Plazomicin
Acetylsalicylic acid may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Polyestradiol Phosphate
Acetylsalicylic acid may increase the thrombogenic activities of Polyestradiol phosphate.
Polythiazide
The therapeutic efficacy of Polythiazide can be decreased when used in combination with Acetylsalicylic acid.
Potassium Citrate
Acetylsalicylic acid may increase the anticoagulant activities of Potassium Citrate.
Practolol
Acetylsalicylic acid may decrease the antihypertensive activities of Practolol.
Pralatrexate
The serum concentration of Pralatrexate can be increased when it is combined with Acetylsalicylic acid.
Pramlintide
Acetylsalicylic acid may increase the hypoglycemic activities of Pramlintide.
Prasterone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prasterone.
Prasugrel
The risk or severity of adverse effects can be increased when Prasugrel is combined with Acetylsalicylic acid.
Prednicarbate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednicarbate.
Prednisolone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisolone.
Prednisone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisone.
Pregnenolone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Pregnenolone.
Primidone
The metabolism of Acetylsalicylic acid can be increased when combined with Primidone.
Probenecid
The therapeutic efficacy of Probenecid can be decreased when used in combination with Acetylsalicylic acid.
Promestriene
Acetylsalicylic acid may increase the thrombogenic activities of Promestriene.
Propafenone
Acetylsalicylic acid may decrease the antihypertensive activities of Propafenone.
Propranolol
Acetylsalicylic acid may decrease the antihypertensive activities of Propranolol.
protein C, human
Acetylsalicylic acid may increase the anticoagulant activities of Protein C.
protein S, human
Acetylsalicylic acid may increase the anticoagulant activities of Protein S human.
Protocatechualdehyde
Acetylsalicylic acid may increase the anticoagulant activities of Protocatechualdehyde.
Pyrimethamine
The metabolism of Acetylsalicylic acid can be decreased when combined with Pyrimethamine.
Quinapril
The therapeutic efficacy of Quinapril can be decreased when used in combination with Acetylsalicylic acid.
Quinestrol
Acetylsalicylic acid may increase the thrombogenic activities of Quinestrol.
Quinethazone
The therapeutic efficacy of Quinethazone can be decreased when used in combination with Acetylsalicylic acid.
Quinine
The metabolism of Acetylsalicylic acid can be decreased when combined with Quinine.
Rabeprazole
The metabolism of Acetylsalicylic acid can be decreased when combined with Rabeprazole.
Ramipril
The therapeutic efficacy of Ramipril can be decreased when used in combination with Acetylsalicylic acid.
Ranolazine
The serum concentration of Acetylsalicylic acid can be increased when it is combined with Ranolazine.
Regular Insulin, Human
Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Human.
Repaglinide
Acetylsalicylic acid may increase the hypoglycemic activities of Repaglinide.
Rescinnamine
The therapeutic efficacy of Rescinnamine can be decreased when used in combination with Acetylsalicylic acid.
Reteplase
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Reteplase.
Reviparin
Acetylsalicylic acid may increase the anticoagulant activities of Reviparin.
Reviparin sodium
Acetylsalicylic acid may increase the anticoagulant activities of Reviparin.
Rifampin
The metabolism of Acetylsalicylic acid can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Acetylsalicylic acid can be increased when combined with Rifapentine.
Rimexolone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Rimexolone.
Risedronate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Risedronate.
Risedronic Acid
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Risedronate.
Rivaroxaban
Acetylsalicylic acid may increase the anticoagulant activities of Rivaroxaban.
Rofecoxib
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Rofecoxib.
Rosiglitazone
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Rosiglitazone.
Rosoxacin
Acetylsalicylic acid may increase the neuroexcitatory activities of Rosoxacin.
Rucaparib
The metabolism of Acetylsalicylic acid can be decreased when combined with Rucaparib.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Acetylsalicylic acid.
Salicylamide
The risk or severity of adverse effects can be increased when Salicylamide is combined with Acetylsalicylic acid.
Saralasin
The risk or severity of adverse effects can be increased when Saralasin is combined with Acetylsalicylic acid.
Sarilumab
Sarilumab may increase the immunosuppressive activities of Acetylsalicylic acid.
Saxagliptin
Acetylsalicylic acid may increase the hypoglycemic activities of Saxagliptin.
Saxagliptin Anhydrous
Acetylsalicylic acid may increase the hypoglycemic activities of Saxagliptin.
Secobarbital
The metabolism of Acetylsalicylic acid can be increased when combined with Secobarbital.
Selexipag
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Selexipag.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Serrapeptase is combined with Acetylsalicylic acid.
Sertraline
Sertraline may increase the antiplatelet activities of Acetylsalicylic acid.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Acetylsalicylic acid.
Sildenafil
The metabolism of Acetylsalicylic acid can be decreased when combined with Sildenafil.
Sisomicin
Acetylsalicylic acid may decrease the excretion rate of Sisomicin which could result in a higher serum level.
Sitagliptin
Acetylsalicylic acid may increase the hypoglycemic activities of Sitagliptin.
Sitagliptin Phosphate
Acetylsalicylic acid may increase the hypoglycemic activities of Sitagliptin.
Sodium Citrate
Acetylsalicylic acid may increase the anticoagulant activities of Sodium Citrate.
Sodium Phosphate
Sodium phosphate may increase the nephrotoxic activities of Acetylsalicylic acid.
Sodium Phosphate, Monobasic
Sodium phosphate may increase the nephrotoxic activities of Acetylsalicylic acid.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Sodium phosphate may increase the nephrotoxic activities of Acetylsalicylic acid.
Sorafenib
The metabolism of Acetylsalicylic acid can be decreased when combined with Sorafenib.
Sotalol
Acetylsalicylic acid may decrease the antihypertensive activities of Sotalol.
Sparfloxacin
Acetylsalicylic acid may increase the neuroexcitatory activities of Sparfloxacin.
Spirapril
The therapeutic efficacy of Spirapril can be decreased when used in combination with Acetylsalicylic acid.
Spironolactone
Acetylsalicylic acid may decrease the antihypertensive activities of Spironolactone.
Streptokinase
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Streptokinase.
Streptomycin
Acetylsalicylic acid may decrease the excretion rate of Streptomycin which could result in a higher serum level.
Sulfadiazine
The metabolism of Acetylsalicylic acid can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Acetylsalicylic acid can be decreased when combined with Sulfamethoxazole.
Sulfisoxazole
The metabolism of Acetylsalicylic acid can be decreased when combined with Sulfisoxazole.
Sunitinib
Acetylsalicylic acid may increase the hypoglycemic activities of Sunitinib.
synthetic conjugated estrogens, A
Acetylsalicylic acid may increase the thrombogenic activities of Synthetic Conjugated Estrogens, A.
synthetic conjugated estrogens, B
Acetylsalicylic acid may increase the thrombogenic activities of Synthetic Conjugated Estrogens, B.
Tacrolimus
Acetylsalicylic acid may increase the nephrotoxic activities of Tacrolimus.
Tafluprost
The therapeutic efficacy of Tafluprost can be decreased when used in combination with Acetylsalicylic acid.
Talinolol
Acetylsalicylic acid may decrease the antihypertensive activities of Talinolol.
Talniflumate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Talniflumate.
Tamoxifen
The metabolism of Acetylsalicylic acid can be decreased when combined with Tamoxifen.
Technetium Tc 99m Medronate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Technetium Tc-99m medronate.
Telmisartan
The risk or severity of adverse effects can be increased when Telmisartan is combined with Acetylsalicylic acid.
Temafloxacin
Acetylsalicylic acid may increase the neuroexcitatory activities of Temafloxacin.
Tenecteplase
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Tenecteplase.
Tenofovir Disoproxil
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Tenofovir disoproxil.
Terbutaline
Acetylsalicylic acid may decrease the antihypertensive activities of Terbutaline.
Terbutaline Sulfate
Acetylsalicylic acid may decrease the antihypertensive activities of Terbutaline.
Teriflunomide
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Acetylsalicylic acid.
Tertatolol
Acetylsalicylic acid may decrease the antihypertensive activities of Tertatolol.
Tibolone
Acetylsalicylic acid may increase the thrombogenic activities of Tibolone.
Ticagrelor
Acetylsalicylic acid may increase the antiplatelet activities of Ticagrelor.
Ticlopidine
The risk or severity of adverse effects can be increased when Ticlopidine is combined with Acetylsalicylic acid.
Tiludronate
The serum concentration of Tiludronic acid can be decreased when it is combined with Acetylsalicylic acid.
Tiludronic Acid
The serum concentration of Tiludronic acid can be decreased when it is combined with Acetylsalicylic acid.
Timolol
Acetylsalicylic acid may decrease the antihypertensive activities of Timolol.
Timolol Anhydrous
Acetylsalicylic acid may decrease the antihypertensive activities of Timolol.
Tinzaparin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Tinzaparin.
Tinzaparin sodium
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Tinzaparin.
Tipranavir
Tipranavir may increase the antiplatelet activities of Acetylsalicylic acid.
Tirofiban
The risk or severity of adverse effects can be increased when Tirofiban is combined with Acetylsalicylic acid.
Tixocortol
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Tixocortol.
Tobramycin
Acetylsalicylic acid may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Tolazamide
Acetylsalicylic acid may increase the hypoglycemic activities of Tolazamide.
Tolbutamide
The metabolism of Acetylsalicylic acid can be decreased when combined with Tolbutamide.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Acetylsalicylic acid.
Torsemide
The therapeutic efficacy of Torasemide can be decreased when used in combination with Acetylsalicylic acid.
Tositumomab
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Tositumomab.
Trandolapril
The therapeutic efficacy of Trandolapril can be decreased when used in combination with Acetylsalicylic acid.
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Acetylsalicylic acid.
Trapidil
The risk or severity of adverse effects can be increased when Trapidil is combined with Acetylsalicylic acid.
Travoprost
The therapeutic efficacy of Travoprost can be decreased when used in combination with Acetylsalicylic acid.
Treprostinil
The risk or severity of adverse effects can be increased when Treprostinil is combined with Acetylsalicylic acid.
Triamterene
Acetylsalicylic acid may decrease the antihypertensive activities of Triamterene.
Tribenoside
The risk or severity of adverse effects can be increased when Tribenoside is combined with Acetylsalicylic acid.
Trichlormethiazide
The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Acetylsalicylic acid.
Triflusal
The risk or severity of adverse effects can be increased when Triflusal is combined with Acetylsalicylic acid.
Trimethoprim
The metabolism of Acetylsalicylic acid can be decreased when combined with Trimethoprim.
Trisodium Citrate Anhydrous
Acetylsalicylic acid may increase the anticoagulant activities of Sodium Citrate.
Trovafloxacin
Acetylsalicylic acid may increase the neuroexcitatory activities of Trovafloxacin.
Troxerutin
Acetylsalicylic acid may increase the anticoagulant activities of Troxerutin.
UNOPROSTONE
The therapeutic efficacy of Unoprostone can be decreased when used in combination with Acetylsalicylic acid.
Urokinase
Acetylsalicylic acid may increase the anticoagulant activities of Urokinase.
Valdecoxib
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Valdecoxib.
Valproate
The serum concentration of Valproic Acid can be increased when it is combined with Acetylsalicylic acid.
Valproic Acid
The serum concentration of Valproic Acid can be increased when it is combined with Acetylsalicylic acid.
Valsartan
The metabolism of Acetylsalicylic acid can be decreased when combined with Valsartan.
Vancomycin
The serum concentration of Vancomycin can be increased when it is combined with Acetylsalicylic acid.
Vemurafenib
The serum concentration of Acetylsalicylic acid can be increased when it is combined with Vemurafenib.
Venlafaxine
Venlafaxine may increase the antiplatelet activities of Acetylsalicylic acid.
Verapamil
Verapamil may increase the anticoagulant activities of Acetylsalicylic acid.
Vitamin E
Vitamin E may increase the antiplatelet activities of Acetylsalicylic acid.
Vorapaxar
The risk or severity of adverse effects can be increased when Vorapaxar is combined with Acetylsalicylic acid.
Voriconazole
The metabolism of Acetylsalicylic acid can be decreased when combined with Voriconazole.
Warfarin
Acetylsalicylic acid may increase the anticoagulant activities of Warfarin.
Zafirlukast
The metabolism of Acetylsalicylic acid can be decreased when combined with Zafirlukast.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Acetylsalicylic acid.
Zofenopril
The therapeutic efficacy of Zofenopril can be decreased when used in combination with Acetylsalicylic acid.
Zoledronic Acid
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Zoledronic acid.
Zoledronic Acid Anhydrous
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Zoledronic acid.
Zomepirac
The risk or severity of adverse effects can be increased when Zomepirac is combined with Acetylsalicylic acid.
